11/10/21

Vaccinex, Inc. to Present at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

11/09/21

Vaccinex, Inc. to Present at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

11/08/21

Vaccinex Reports Third Quarter 2021 Financial Results and Provides Corporate Update

11/04/21

Vaccinex, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference

11/01/21

Vaccinex to Present at the Virtual Huntington’s Study Group Meeting on November 4-6, 2021

09/17/21

Vaccinex to Present at the Oppenheimer & Co. Inc. Fall Healthcare Life Sciences and MedTech Summit

09/15/21

Vaccinex CEO, Dr. Maurice Zauderer, Presented New and Promising Phase 2 SIGNAL Trial Data in a Plenary Session at the European Huntington’s Disease Network Meeting

08/16/21

Vaccinex Reports Second Quarter 2021 Financial Results and Provides Corporate Update

06/30/21

Vaccinex to Chair Panel Q&A Session and Present Poster at the XV European Meeting on Glial Cells in Health and Disease

06/08/21

Vaccinex Announces Activation of Clinical Sites to Enroll Patients in Studies of Pepinemab as Single Agent in Alzheimer’s Disease and in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

05/19/21

Vaccinex to Present at the Jefferies 2021 Virtual Healthcare Conference

05/17/21

Vaccinex Reports First Quarter 2021 Financial Results and Provides Corporate Update

04/21/21

Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research

03/16/21

Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

03/11/21

Vaccinex to Present at the Oppenheimer 31st Annual Healthcare Conference

02/22/21

Vaccinex Announces Licensing of Anti-CCR8 Antibody to Surface Oncology

02/19/21

Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform

01/05/21

Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event